Member Info for Jurado

That's quite an exciting report. I'm a bit mystified as to why they put estimated revenue for the year to 01.16 as just 0.4m. The interims have us doing 0.3m up to the end of July. Am I missing something or are they?

Well, that appears to have been the scenario. Progress, but not especially exciting figures, though seemingly more or less what the market expected, and we all just have to wait a bit longer. See you all in six months.

Big day coming up for us on Monday. Have to hope that the fall over last two months (well 18 months but the last two in particular) mean that any poor to average figures will have been priced in somewhat. I keep telling myself this is still early days for a biomedical company - but it would be good to get some positive progress on sales of dermapure. I'm quietly confident.

So what's with all these sells this month? Any Ideas? They can't all be misreported buys.

Seeing they've arranged a capital markets day to coincide with the interim results announcement in October, would it be too much to infer that they might have good news to share?

...erm, that's US dollars according to the RNS. Or is there some confusion mash-up here between the US and Bahrain contracts?

Bizarre. Can only assume it will creep back up during the day as people come to their senses.

Ok, so now we do have the results for 2014. We now look a financially sound company in search of something to do.

Hmm, ignore that last post - just noticed the article put up on Friday by yahoo refers to 2011 - presumably some kind of automated glitch saw it being reposted.

Having read the results this morning I assumed there would be something of a fall as the short -term traders had a look and went "harrumph, still not making money - ooh look squirell!" . However we appear to be recovering that early fall as people realise it's all still to play for here for anyone who can wait a while. I nearly missed the second release today which covered another getting Medicare approval for another two states - maybe this is going to be a regular thing in coming months as our coverage spreads.

No RNS reported here it seems but yahoo is reporting results - still in the red but revenues rose to £19.2m from £16.8m and losses before tax narrowed to £310,000 from £1.88m - https://uk.finance.yahoo.com/news/cellcast-still-red-102700275.html

Actually, looking back to the last interim statement it states "the Group has invested in new genres of interactive multiplatform TV primarily focussing on the gaming and gambling sectors. These new businesses are expected to commence operation in the first quarter of 2015." So maybe it's just that there's a likelihood that we're trading again now. We might get some figures shortly.

I care - to the tune of a £500 punt taken here at this price a few years back. No diea why it's creeping up. The business model of the company has changed beyond recognition since I bought in and I can't say I fully understand what it is they do now, but it once went up to about 6p - I'd be very happy if it did so again.

One of my other holdings - Summit Therapeutics - recently moved to a dual listing on Nasdaq. People on that board were very enthusiastic about this, though in the first few weeks it's not made a big difference to the SP. I do wonder though if this an avenue we may go down here. Currently that's where we're trading and we've got a US registered subsidiary - I'm assuming it would help unlock access to lots of keen US investors. So good idea - or just a distraction at this time?

So, the company just tweeted a picture of this morning's breakfast presentation - looks like a very healthy turnout. Hope that's good sign, and hopefully we'll get details of the information presented soon too.

You've got to love a special divi. Only around £40 for me but that's £40 I didn't have yesterday and there's a good bottle of Scotch with my name on it now with which to toast our sales staff and customers.

Excellent - a couple of months back I was bemoaning the lack of information on how things were going. Obviously sales figures are what will drive long-term growth but a few compelling case studies are good for everyone's morale - not least the patients' of course.

Wouldn't have thought it had to be insider trading based on genuine information - just a sentiment that gets shared around the market which may be based on research or might just be straws in the wind. The last figures were based on just a couple of weeks sales and given we've not had official information I'm not that surprised if some traders get cold feet a few weeks before the next market update.

Ok, so this is all a bit depressing. Trying to be positive - if there is to be poor figures relating to the dermapura launch, I reckon this is being clearly priced in by the market. Bad news shouldn't taken it down much further, good news should see a big bounceback. Of course it's still early days for dermapure and anyway there's other things in the pipeline too. This fall is a buying opportunity.

Well I*'ve seen this fall described elsewhere as being "investors dumping stock in advance of May's figures" but - despite that one huge sale a week or so back - I've not heard anything to justify that course of action. I agree with your assessment of the company and all I can say is this is probably the time to hunker down and wait. A shame we've not heard a bit more from the company.